Lannett Company, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 97   

Articles published

LCI 55.39 +0.66 (1.21%)
price chart
The Market Is Wrong On Lannett (LCI)
Lannett (NYSE:LCI) is down more than 20% since mid-April and the market clearly did not like the fiscal Q3 report. The company guided for low single-digit revenue growth in fiscal 2016 which may have caused the recent share price correction, but those ...
Reasons for Arthur Bedrosian's Shares Unload of Lannett Company, Inc. (NYSE ...
Arthur Bedrosian; that is an insider in Lannett Company, Inc. (NYSE:LCI) 55.80 +0.94 1.71% who is the latest to sell shares in the firm for which he is currently the CEO.
Insider Selling: Arthur P. Bedrosian Sells 5000 Shares of Lannett Company ...  WKRB News
Lannett Co Inc (LCI) Insider Buying : James M. Maher Buys 250 Shares.
Lannett Co Inc (LCI): James M. Maher , the director of Lannett Co Inc purchased 250 shares on May 21, 2015. The Insider buying transaction was disclosed on May 21, 2015 to the Securities and Exchange Commission.
Lannett Company, Inc. (NYSE:LCI)'s Insider Arthur Bedrosian Sells 5000 Shares
Lannett Company, Inc. (NYSE:LCI) 55.35 +0.49 0.89% 's CEO Arthur Bedrosian unloaded 5,000 shares of the company's stock in an open market transaction dated May 18, 2015.
Philly drugmaker Lannett buys Silarx for $42 million  Philly.com (blog)
Investment Analysts' Recent Ratings Changes for Lannett Company (LCI)  The Legacy
Pre Movers- Lannett Company, Inc. (NYSE:LCI), Intel Corporation (NASDAQ ...
Lannett Company, Inc. (NYSE:LCI) [Trend Analysis] declared that it has reached into a definitive accord to purchase privately held, Silarx Pharmaceuticals, Inc. and a related real estate entity, a manufacturer and marketer of liquid generic ...
Stocks in Focus: The Coca-Cola Company (NYSE:KO), China Mobile Games ...  Property Mentor
Lannett Company, Inc. (NYSE:LCI) Looking for a Significant EPS growth for the ...
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States.
Zacks' Bull Of The Day: Lannett (LCI)  Seeking Alpha (registration)
Lannett Has A Bright Future Ahead (LCI)
Lannett's (NYSE:LCI) share value has gone up by 41% in a year. The company is a manufacturer of generic thyroid, cardiovascular and pain-management drugs.
Lannett Company: Nearing Cheap Levels (NYSE:LCI)
We look at Lannett Company, Inc. (NYSE:LCI) [Trend Analysis] a company in the healthcare industry which lately stock market players have been interested in, to assess if it provides value for investors considering buying or selling it.
Philadelphia drug company subpoenaed, stock price falls
Lannett Co. Inc.'s stock price dropped more than 8 percent in mid-day trading Thursday after the Northeast Philadelphia generic pharmaceutical company announced that it was hit with a grand jury subpoena this week.
Lannett Company Earns "Buy" Rating from Roth Capital (LCI)
Also, Roth Capital gave shares of BioDelivery Sciences International, Inc. a new $14.00 price target. They now have a buy rating on that stock.